Regulatory tool
China cosmetic ingredient inventory search
Brazil follows the MERCOSUR technical framework; prohibitions and restrictions are issued as RDC resolutions that reference the MERCOSUR common lists. Transcribed from third-party legal databases (LegisWeb, Cosmetoguia): prohibited list = RDC 83/2016 annex plus the 8 substances added by RDC 529/2021; restricted list and fragrance allergens from RDC 530/2021; preservatives RDC 528/2021; UV filters RDC 600/2022. The colorant list (RDC 628/2022) is not yet included (scanned copies only). The ANVISA / DOU text prevails. Transcribed from third-party legal databases (LegisWeb, Cosmetoguia): prohibited list = RDC 83/2016 annex plus the 8 substances added by RDC 529/2021; restricted list and fragrance allergens from RDC 530/2021; preservatives RDC 528/2021; UV filters RDC 600/2022. The colorant list (RDC 628/2022) is not yet included (scanned copies only). The ANVISA / DOU text prevails.
Arama yalnızca Çince ve İngilizceyi kapsar — lütfen İngilizce bir terim veya INCI adı kullanın.
3 entries
| ID | Chemical name / description | INCI name | CAS No. | Function · Annex · Limit |
|---|---|---|---|---|
| BR-530/II-16 | Eugenol | EUGENOL | 97-53-0 | 香精致敏原 · RDC 530/2021 附件 II 第 16 项 · 驻留型 >0.001%、淋洗型 >0.01% 须在标签标注 |
| BR-530/II-22 | Isoeugenol | ISOEUGENOL | 97-54-1 | 香精致敏原 · RDC 530/2021 附件 II 第 22 项 · 驻留型 >0.001%、淋洗型 >0.01% 须在标签标注 |
| BR-83/451 | Metileugenol, exceto o teor normal nas essências naturais, e desde que a concentração não exceda: a) 0,02 % em fragrâncias finas b) 0,008 % em água de toilette c) 0,004 % em cremes perfumados d) 0,001 % em produtos destinados a serem enxaguados e) 0,0004 % em outros produtos não destinados a serem rformer name:IFRA | Metileugenol, exceto o teor normal nas essências naturais, e desde que a concentração não exceda: a) 0,02 % em fragrâncias finas b) 0,008 % em água de toilette c) 0,004 % em cremes perfumados d) 0,001 % em produtos destinados a serem enxaguados e) 0,0004 % em outros produtos não destinados a serem r | 93-15-2 | 禁用 · RDC 83/2016 附件第 451 项(GMC 62/14) · 欧盟附录 II 序号 IFRA · EC 202-223-0 |
Source: ANVISA. Reproduced from the official list without additions or changes. Listing is not approval; limits and conditions follow the latest official text.
Need to confirm whether an ingredient is usable in your target market? Send us the formulation direction.